-transparent.png){kind=logo}
Monofunctional alkylating agents which react predominantly at nitrogen atoms in DNA bases (e.g. alkyl methanesulphonates, dialkylsulfates) are generally weak carcinogens whereas compounds which lead extensively to oxygen alkylation (e.g. alkylnitrosoureas, dialkylnitrosamines, dialkyl-aryltriazenes) often exhibit a strong carcinogenic activity. O6-Alkylation of guanine is a promutagenic DNA modification possibly involved in the initiation of malignant transformation. O6-Alkylguanine can be enzymically excised and in the rat the induction of neural, renal and colonic tumors by alkylnitrosoureas, 3,3-dimethyll-phenyltriazene, dimethylnitrosamine and 1,2-dimethylhydrazine correlates with an excision repair deficiency in the target tissue. However, species and strain differences in the response to these carcinogens are not paralleled by differences in the excision repair capacity for O6-alkylguanine. Preliminary data suggest that in rat liver there is an inducible enzyme for the removal of O6-alkylguanine from DNA.
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
January 1983,
IARC scientific publications,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
January 1980,
British medical bulletin,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
December 1968,
Food and cosmetics toxicology,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
May 1977,
Nature,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
September 1971,
Cancer research,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
August 1975,
British journal of cancer,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
January 1970,
Zeitschrift fur Krebsforschung,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
January 1969,
Mutation research,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
August 2002,
International journal of clinical pharmacology and therapeutics,
P Kleihues, and
G Doerjer, and
J A Swenberg, and
E Hauenstein, and
J Bücheler, and
H K Cooper
April 2005,
Current gene therapy,
